Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis

Summary

The efficacy of vaccination against influenza in patients with rheumatoid arthritis has been assessed using humoral response. However, the cellular immunity is another important pathway of response to vaccination. The purpose of this study is to evaluate the degree of cellular immunity response to influenza vaccination. Patient with rheumatoid arthritis and healthy controls will participate in this study , will undergo a clinical evaluation the day of vaccination and 4 weeks after. The humoral and cell immunity response will be assessed the day of vaccination and 4 weeks later

Timeline

Start

2009-10

Primary completion

2010-03

Completion

2010-04

Drugs

Indications